JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bannon, M. J.
Right arrow Articles by Bonner, T. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bannon, M. J.
Right arrow Articles by Bonner, T. I.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 261, Issue 15, 6640-6642, May, 1986

Dopamine antagonist haloperidol decreases substance P, substance K, and preprotachykinin mRNAs in rat striatonigral neurons

MJ Bannon, JM Lee, P Giraud, A Young, HU Affolter and TI Bonner

Rat genomic clones were used to quantitate preprotachykinin mRNAs in the rat basal ganglia, while the tachykinin peptide products substance P and substance K were measured by radioimmunoassay. Administration of the dopamine antagonist (antipsychotic) drug haloperidol significantly decreased substance P, substance K, and both alpha (substance P encoding) and beta (substance P/substance K encoding) preprotachykinin mRNAs, suggesting a drug-induced decrease in striatonigral tachykinin biosynthesis. The time course for decreased preprotachykinin mRNAs and tachykinins apparently parallels the period of maximum risk for the development of certain antipsychotic drug-induced extrapyramidal side effects seen clinically. Tachykinin interaction with dopamine neurons may play an important role in the modulation of basal ganglia function.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
P. R. Dobner, J. Fadel, N. Deitemeyer, R. E. Carraway, and A. Y. Deutch
Neurotensin-deficient mice show altered responses to antipsychotic drugs
PNAS, June 20, 2001; (2001) 141042198.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. J. Morris and B. J. Morris
Stimulation of Immediate Early Gene Expression in Striatal Neurons by Nitric Oxide
J. Biol. Chem., October 20, 1995; 270(42): 24740 - 24744.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
A.J. Stoessl
Peptide-dopamine interactions in the central nervous system: implications for neuropsychiatric disorders
J Psychopharmacol, January 1, 1989; 3(2): 99 - 120.
[PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. R. Dobner, J. Fadel, N. Deitemeyer, R. E. Carraway, and A. Y. Deutch
Neurotensin-deficient mice show altered responses to antipsychotic drugs
PNAS, July 3, 2001; 98(14): 8048 - 8053.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1986 by the American Society for Biochemistry and Molecular Biology.